The Graduate School, together with the Center for Career Readiness and Life Skills, invites you to attend Industry Insights, a series of virtual events designed to introduce graduate students and postdocs to a variety of industries. Each series will be held online and will feature working professionals from different industries. The discussions will be based on the skills required to enter and succeed in these industries.

The first series of the program, taking place in the spring of 2026, will focus on the biotech and pharmaceutical industries.

The online events will take place:

• Friday, January 30, 2026, 12:00 PM – 1:00 PM (NOTE: Date change)
  • Video recording available: https://www.youtube.com/watch?v=ULCs2p8meBI
• Monday, February 23, 2026, 12:00 PM – 1:00 PM
• Monday, March 30, 2026, 12:00 PM – 1:00 PM
• Monday, April 27, 2026, 12:00 PM – 1:00 PM

To register for any of the events, please visit this link. Once registered, you will receive the link to attend virtually.

Second Session: Monday, February 23, 2026, 12:00 PM – 1:00 PM

Speakers include:

Martha Brown, Executive Director, Discovery Research Site Strategy and Operations, Boehringer Ingelheim

Dr. Martha Brown is the Executive Director of Discovery Research Site Strategy and Operations at Boehringer Ingelheim Pharmaceuticals. With a 27‑year tenure at the company, she has held a range of strategic and scientific leadership roles across Research and Development. Her experience includes leading High Throughput Screening and overseeing Structural Biology for all on‑site small‑molecule research programs.

Dr. Brown earned her PhD in Biology from The Johns Hopkins University and has dedicated her career to advancing scientific innovation, operational excellence, and the advancement of innovative therapies that bring meaningful benefit to patients in need.

O. Hecmarie Melendez-Fernandez, Associate Director, Precision Medicine & Diagnostics, Eli Lilly and Company

Hecmarie Meléndez-Fernández, PhD, is a Neuroscientist by training, and serves as an Associate Director in Precision Medicine Diagnostics at Eli Lilly & Company. Her industry experience spans clinical trial management, project portfolio management, medical content creation focused on clinical care care gaps and disease state education. 

Hecmarie was born and raised in Puerto Rico, where she completed her undergraduate degree in Integrative Biology, at the University of Puerto Rico – Río Piedras. Initially focused in academia, Hecmarie pursued multiple academic and research opportunities within Neuroscience, obtaining a T32 fellowship from the NIH, a CLIMB fellowship from NIGMS, an SfN Neuroscience Scholars Fellowship, among others, working at Baylor College of Medicine, The Ohio State University, Northwestern and West Virginia University. Her doctoral dissertation focused on understanding the effects of disrupted circadian rhythms on aortic endothelial function, metabolism and sleep, within the context of sex differences. 

Hecmarie is passionate about supporting people from underrepresented backgrounds in science, so they can achieve their maximum potential and career goals, just as she has. In graduate school she developed the Non-Academic Careers in Science seminar series, where she coordinated webinars with PhD-holding scientists outside academia, to educate current graduate students on careers outside the traditional academic research path. She has a long-standing history of leading and participating in outreach and service efforts, such as Científico Latino, in which she has volunteered in different capacities, since 2023. Additionally, she participates in mentorship and outreach opportunities through local organizations (e.g., Girls Inc, Indiana Latino Institute, Project Stepping Stone, etc.), where she provides scientific and professional development support. Knowing how important this support has been in her development, and how she can also positively impact others, her motto is “Pay It Forward”.

To register: Visit this link.

____________________________________________________________________________

First Session: Friday, January 30, 2026, 12:00 PM – 1:00 PM (NOTE: Date Change)

Speakers include:

Manisha Sinha, Founder of Clarity Bio

Manisha Sinha, Ph.D., is a strategic R&D leader, a well-published translational biologist, founder of Clarity Bio, and an adjunct faculty member with a proven track record of advancing programs from target validation to clinical candidates. With 12+ years of experience at Biogen and high-growth biotechs, she leads multi-disciplinary teams to advance complex therapies while mentoring the next generation of scientists to lead with data-driven rigor and operational excellence in the life sciences industry.

Cassandra Tierney, Senior Principal Scientist and Lab Head, Pfizer

Cassandra Tierney, PhD is a Senior Principal Scientist and Lab Head at Pfizer, where she leads a CLIA‑regulated genomics laboratory dedicated to advancing biomarker strategies and delivering pharmacogenomics insights that inform drug exposure in clinical trials. With deep expertise in qPCR, NGS, digital PCR, and the development of laboratory‑developed tests, Cassandra combines scientific rigor with a passion for mentorship. She actively supports early‑career scientists through her role as a mentor in Pfizer’s R&D rotational program and continues to teach as an adjunct instructor in human biology. Cassandra earned her PhD in Molecular & Cell Biology (Genetics) from the University of Connecticut.

First Session available here: https://www.youtube.com/watch?v=ULCs2p8meBI